These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6809386)

  • 1. Intensified nutrition as an adjunct to cytotoxic chemotherapy in gynaecological cancer patients.
    Nuutinen LS; Kauppila A; Ryhänen P; Niinimäki A; Kivinen S; Saarela M; Pakarinen A; Hollmén A
    Clin Oncol; 1982 Jun; 8(2):107-12. PubMed ID: 6809386
    [No Abstract]   [Full Text] [Related]  

  • 2. Hexamethylmelamine-CAF (cyclophosphamide, methotrexate, and 5-FU) and cisplatin-CAF in refractory ovarian cancer.
    Sessa C; D'Incalci M; Valente I; Bolis G; Colombo N; Mangioni C
    Cancer Treat Rep; 1982 May; 66(5):1233-4. PubMed ID: 6805951
    [No Abstract]   [Full Text] [Related]  

  • 3. [A randomized clinical trial of cyclophosphamide versus adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate in advanced ovarian carcinoma--a preliminary report ].
    Chylak V; Ilijas M; Krusić J; Kolarić K
    Lijec Vjesn; 1982; 104(3-4):120-2. PubMed ID: 6750298
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of advanced adenocarcinoma of the lung with ftorafur, doxorubicin, cyclophosphamide, and cisplatin (FACP) and intensive iv hyperalimentation.
    Jordan WM; Valdivieso M; Frankmann C; Gillespie M; Issell BF; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(3-4):197-205. PubMed ID: 6786737
    [No Abstract]   [Full Text] [Related]  

  • 5. Mayo Clinic experience with epithelial ovarian cancer.
    Decker DG
    Clin Obstet Gynaecol; 1983 Aug; 10(2):337-56. PubMed ID: 6413115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of cytotoxic chemotherapy in conjunction with gynaecological surgery.
    Guthrie D
    Clin Obstet Gynaecol; 1978 Dec; 5(3):709-27. PubMed ID: 367674
    [No Abstract]   [Full Text] [Related]  

  • 7. [Progress in the chemotherapy of ovarian cancer].
    Honetz N
    Wien Med Wochenschr; 1982 Jul; 132(13-14):319-24. PubMed ID: 6291259
    [No Abstract]   [Full Text] [Related]  

  • 8. [Polymer-drug complexes in the treatment of extensive ovarian cancer].
    Novikova EG; Borisov VI; Dmitriev DG; Zel'vin BM; Karseladze AI; Shchitkov KG; Li AD
    Sov Med; 1991; (11):27-9. PubMed ID: 1767307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ovarian adenocarcinoma stage III and IV treated by a combination of adriamycin, cyclophosphamide, 5-fluorouracil and cis-DDP. Therapeutic role of cis-DDP in this combination].
    Pouillart P; Bretaudeau B; Palangie T; Jouve M; Garcia-Giralt E; Asselain B
    Bull Cancer; 1982; 69(5):434-42. PubMed ID: 6891903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possibilities and value of intracavitary and systemic chemotherapy of bladder cancer].
    Hofmann W; Langkopf B
    Z Urol Nephrol; 1982 Dec; 75(12):889-95. PubMed ID: 6819737
    [No Abstract]   [Full Text] [Related]  

  • 11. [Phase III study of cisplatin on gynecological malignancy].
    Chen JT; Takizawa K; Kawana T; Kawagoe K; Yoshida R; Yoshikawa H; Mizuno M; Sakamoto S
    Nihon Gan Chiryo Gakkai Shi; 1982 Apr; 17(3):710-9. PubMed ID: 6182259
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic chemotherapy of bladder cancer].
    Seematter RJ
    Helv Chir Acta; 1982 Aug; 49(3-4):339-43. PubMed ID: 6890050
    [No Abstract]   [Full Text] [Related]  

  • 14. Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
    Kelsen D; Gralla R; Stoopler M; Casper E; Cheng E; Kosloff C; Golbey R
    Cancer Treat Rep; 1982 Feb; 66(2):247-51. PubMed ID: 7034932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin sensitivity of ovarian cancer in the histoculture drug response assay correlates to clinical response to combination chemotherapy with cisplatin, doxorubicin and cyclophosphamide.
    Ohie S; Udagawa Y; Kozu A; Komuro Y; Aoki D; Nozawa S; Moossa AR; Hoffman RM
    Anticancer Res; 2000; 20(3B):2049-54. PubMed ID: 10928150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advanced epithelial cancers of the ovary: results of 4 chemotherapy protocols (110 cases)].
    Israël L; Lepage E; Breau JL; Aguilera J
    Bull Cancer; 1982; 69(5):426-33. PubMed ID: 6891902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relation between sex hormone binding globulin and response to cytotoxic chemotherapy (CAF therapy) in breast cancer.
    Murayama Y; Nagashima M; Aoyagi K; Asano K
    Nihon Gan Chiryo Gakkai Shi; 1980 Jun; 15(3):334-8. PubMed ID: 7190994
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T; Vance R; Puneky L; Khansur T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].
    Pérez JE; Machiavelli M; Romero A; Leone BA; Rabinovich MG; Arévalo E
    Medicina (B Aires); 1982; 42(6 Pt 1):587-95. PubMed ID: 6897849
    [No Abstract]   [Full Text] [Related]  

  • 20. [Surgical method and combination chemotherapy in treating stage-III and IV ovarian cancer].
    Grigorova TM; Vartanian LG; Marenich AF
    Vopr Onkol; 1980; 26(2):81-5. PubMed ID: 6767311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.